Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06736587
PHASE1
Phase 1 Clinical Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP212525 in Healthy Volunteers
Sponsor: Daewoong Pharmaceutical Co. LTD.
View on ClinicalTrials.gov
Summary
The safety and tolerability of single and multiple administration of DWP212525
Official title: A Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose, Dose-escalation Phase 1 Clinical Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP212525 in Healthy Volunteers
Key Details
Gender
All
Age Range
19 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
84
Start Date
2024-12-10
Completion Date
2027-03-30
Last Updated
2026-06-08
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
DWP212525 XXmg
DWP212525 XXmg
DRUG
DWP212525 placebo
DWP212525 placebo
Locations (1)
Seoul National University Hospital
Seoul, South Korea